Skip to main navigation
Skip to search
Skip to main content
Bar-Ilan University Home
Help & FAQ
Link opens in a new tab
Search content at Bar-Ilan University
Home
Researchers
Organisations
Research output
Prizes
Student theses
Courses
Activities
Projects
Press/Media
Datasets
Equipment
HER2-Low Breast Cancer: Current Landscape and Future Prospects
Yelena Shirman
, Shlomit Lubovsky
, Ayelet Shai
Rambam Health Care Campus Israel
Research output
:
Contribution to journal
›
Review article
›
peer-review
45
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'HER2-Low Breast Cancer: Current Landscape and Future Prospects'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Breast Cancer
100%
Human Epidermal Growth Factor Receptor 2 (HER2)
100%
Tumor
22%
Clinical Characteristics
22%
Fluorescence in Situ Hybridization
11%
Non-associated
11%
Molecular Characteristics
11%
Biological Characteristics
11%
Immunohistochemistry
11%
Current Therapeutics
11%
Translational Studies
11%
Tumor Heterogeneity
11%
Antibody-drug Conjugate
11%
Future Therapeutics
11%
Docking Site
11%
Negative Breast Cancer
11%
Human Epidermal Growth Factor Receptor 2-negative
11%
Therapeutic Landscapes
11%
Pathological Use
11%
Medicine and Dentistry
Breast Cancer
100%
Gamma Urogastrone
100%
Epidermal Growth Factor Receptor 2
100%
Neoplasm
20%
Immunohistochemistry
10%
Tumour Heterogeneity
10%
Fluorescence in Situ Hybridization
10%
Antibody-Drug Conjugate
10%
Immunology and Microbiology
Gamma Urogastrone
100%
Antibody Drug Conjugate
10%
Fluorescence in Situ Hybridization
10%